Person

Back to overview

Mölling Karin

Gender Female
Institute Institut für Medizinische Virologie Universität Zürich
Show all

Projects as responsible applicant

Responsible applicant Institution of higher education Start End date Funding scheme

Immunotherapy. Open label Phase I/II study (GMP)
Mölling Karin University of Zurich - ZH 01.01.2001 31.12.2001 NRP 37 Somatic Gene Therapy

Significance of a novel WD-propeller-FYVE protein for signalling
Mölling Karin University of Zurich - ZH 01.04.2007 31.12.2008 Project funding (Div. I-III)

Nucleic acid based intervention of HIV replication
Mölling Karin University of Zurich - ZH 01.04.1997 31.05.2000 Project funding (special)

The role of the Raf kinase in normal and tumor cells during development and tumor formation
Mölling Karin University of Zurich - ZH 01.04.1997 30.11.2000 Project funding (Div. I-III)

Characterization of the nucleocapsid NC-protein of HIV-1
Mölling Karin University of Zurich - ZH 01.06.1994 31.12.1996 Project funding (special)

Analyse der Mil/Raf-Proteinkinase im Signalweg der Zelle
Mölling Karin University of Zurich - ZH 01.04.1994 31.03.1997 Project funding (Div. I-III)

Signalling of the Raf-kinase in complex biological systems
Mölling Karin University of Zurich - ZH 01.12.2000 31.03.2004 Project funding (Div. I-III)

Characterization of the interaction between c-Raf-1 and 14-3-3.
Mölling Karin University of Zurich - ZH 01.07.1995 30.09.1996 International short research visits

Development of vectors for gene therapy
Mölling Karin University of Zurich - ZH 01.02.1997 30.09.2000 NRP 37 Somatic Gene Therapy

Non-proliferative signaling by negative regulation of the Raf kinase cascade
Mölling Karin University of Zurich - ZH 01.10.2004 30.09.2006 Project funding (Div. I-III)

Projects as co-applicant

Responsible applicant Institution of higher education Start End date Funding scheme

The multidomain protein CNK: a regulator of the Raf kinase pathway and integrator of signaling pathways
Radziwill Gerald University of Zurich - ZH 01.06.2004 31.05.2006 Project funding (Div. I-III)

Isolation of c-Myb interacting proteins
Hovens Christopher Martin University of Zurich - ZH 01.10.1995 30.09.1998 Project funding (Div. I-III)

Chemoprotection of hematopoietic cells via topoisomerase IIa
Stahel Rolf University of Zurich - ZH 01.04.1996 31.05.1998 NRP 37 Somatic Gene Therapy

Targeting of dendritic cells for DNA vaccination
Walter Elke ETH Zurich - ETHZ 01.07.1999 31.12.2001 NRP 37 Somatic Gene Therapy

-